ATHLOME LIMITED
Significant control: Prof Yannis Pitsiladis (50–75%), Maria Stefania Kapsali (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Athlome Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Athlome Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
ATHLOME LIMITED is an active private limited company (company number 10505477) incorporated on 1 December 2016, registered in Eastbourne. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2025, showing net assets of £100 and cash of £100, with 0 employees on average. Net assets were unchanged on the prior period.
By net assets it sits in the lower half of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
Ownership and control
- Prof Yannis Pitsiladis
- owns 50–75% of shares
- holds 50–75% of voting rights
- can appoint or remove directors
- can appoint or remove directors
- can appoint or remove directors
- Ms Maria Stefania Kapsali
- owns 25–50% of shares
- holds 25–50% of voting rights
- Dr Brian John Page
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 1 December 20169 yrs ago
- Next accounts due
- 30 September 2027in 339 days
- Confirmation statement due
- 15 December 2026in 50 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | £100 | £100 | — | — | — | — | 0 |
| 31 December 2024 | £100 | £100 | — | — | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £100 at 31 December 2025
- Incorporated five or more years agoIncorporated 1 December 2016
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 339 days
- Confirmation statement duein 50 days
- Accounts period endNet assets £100 · small accounts
- Accounts period endNet assets £100 · small accounts
- Incorporated
Similar companies in Brighton
- OPTCEUTICS LIMITEDBrighton · inc. Feb 2016
- EXOVO LTDBrighton · inc. May 2018
- VEMICO LTDWorthing · inc. Jul 2018
- MICROBIAL GENOMICS LTDHove · inc. Oct 2018
- BENCHMARK GENETICS LIMITEDWorthing · inc. Jul 2014
- ENTERPRISE THERAPEUTICS LTDBrighton · inc. May 2014
All companies incorporated on 1 December 2016 · in Dec 2016.
Reminders for ATHLOME LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.